Cargando…

Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience

BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarvar, Mehrdad, Amirpour, Afshin, Pourmoghaddas, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653263/
https://www.ncbi.nlm.nih.gov/pubmed/23696764
_version_ 1782269403461582848
author Honarvar, Mehrdad
Amirpour, Afshin
Pourmoghaddas, Masoud
author_facet Honarvar, Mehrdad
Amirpour, Afshin
Pourmoghaddas, Masoud
author_sort Honarvar, Mehrdad
collection PubMed
description BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, without using Symplicity catheter. METHODS: 30 Patients who were resistant to at least three types of antihypertensive medical therapy were selected. Patients received percutaneous renal artery denervation, without Symplicity catheter method, and were followed up for 1 week, 1, 3, and 6 months later after treatment. Ambulatory 24-hour blood pressure (BP) Holter was performed 1 week before intervention and after 1 month. The primary outcome was change in 24-hour ambulatory BP and change in office and home-based BP measurements. RESULTS: The mean age of the studied patients was 52 ± 15.4 years and 43.3% (n = 13) were female. Systolic and diastolic BP at baseline was 163 ± 17.2 and 95 ± 8.2 mmHg, respectively. Patients took 3.6 ± 1.3 hypertensive medications. Systolic and diastolic BP at 1-week, 1-month, 3-month and 6-month after renal denervation significantly decreased compared to the baseline (P < 0.0001). Average BP derived from 24-hour ambulatory BP monitoring changed in parallel with office-based BP measurements. Most of patients (50%) who underwent renal denervation had reductions of 10 mmHg or greater in systolic BP and 56.7% of them had reductions of 5 mmHg or greater in diastolic BP. 33.3% of patients also achieved the target of systolic BP less than 140 mmHg and 60% achieved the target of diastolic BP less than 90 mmHg. No patients showed vascular damage at final angiography. CONCLUSION: Catheter based renal ablation was associated with a significant reduction in both systolic and diastolic BP, on top of maximal medical therapy, which persisted throughout 6 months follow-up in the first-in-man study without the Symplicity catheter.
format Online
Article
Text
id pubmed-3653263
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-36532632013-05-21 Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience Honarvar, Mehrdad Amirpour, Afshin Pourmoghaddas, Masoud ARYA Atheroscler Original Article BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, without using Symplicity catheter. METHODS: 30 Patients who were resistant to at least three types of antihypertensive medical therapy were selected. Patients received percutaneous renal artery denervation, without Symplicity catheter method, and were followed up for 1 week, 1, 3, and 6 months later after treatment. Ambulatory 24-hour blood pressure (BP) Holter was performed 1 week before intervention and after 1 month. The primary outcome was change in 24-hour ambulatory BP and change in office and home-based BP measurements. RESULTS: The mean age of the studied patients was 52 ± 15.4 years and 43.3% (n = 13) were female. Systolic and diastolic BP at baseline was 163 ± 17.2 and 95 ± 8.2 mmHg, respectively. Patients took 3.6 ± 1.3 hypertensive medications. Systolic and diastolic BP at 1-week, 1-month, 3-month and 6-month after renal denervation significantly decreased compared to the baseline (P < 0.0001). Average BP derived from 24-hour ambulatory BP monitoring changed in parallel with office-based BP measurements. Most of patients (50%) who underwent renal denervation had reductions of 10 mmHg or greater in systolic BP and 56.7% of them had reductions of 5 mmHg or greater in diastolic BP. 33.3% of patients also achieved the target of systolic BP less than 140 mmHg and 60% achieved the target of diastolic BP less than 90 mmHg. No patients showed vascular damage at final angiography. CONCLUSION: Catheter based renal ablation was associated with a significant reduction in both systolic and diastolic BP, on top of maximal medical therapy, which persisted throughout 6 months follow-up in the first-in-man study without the Symplicity catheter. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2013-01 /pmc/articles/PMC3653263/ /pubmed/23696764 Text en © 2013 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Honarvar, Mehrdad
Amirpour, Afshin
Pourmoghaddas, Masoud
Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title_full Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title_fullStr Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title_full_unstemmed Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title_short Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
title_sort renal ablation for treatment of hypertension without symplicity catheter: the first human experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653263/
https://www.ncbi.nlm.nih.gov/pubmed/23696764
work_keys_str_mv AT honarvarmehrdad renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience
AT amirpourafshin renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience
AT pourmoghaddasmasoud renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience